LIABILITY REGULATION ISSUES IN THE USE OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE

2026

Closed access Metadata (CSL-JSON)
DOI 10.52026/2788-5291_2026_81_2_334
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

The article examines the issues in regulating liability for the use of artificial intelligence in healthcare. It analyzes the existing system in Kazakhstan for imposing legal liability for medical offenses and assesses how liability is regulated whe harm results from the use of artificial intelligence. It is started that despite the potential of artificial intelligence in healthcare, the risk of harm to life and health remains high. At the same time, risks may arise not only from artificial intelligence itself, but also from shortcomings or absence of regulation. The article addresses regulation of artificial intelligence registered as a medical device and the specifics of allocating liability between the medical device manufacturer and the medical organization. Based on a review of scientific publications, the paper analyzes various approaches to liability in medical legal relations in domestic and international practice that may help reduce the risks of using artificial intelligence and increase public trust. The author substantiates the need for consistent regulation based on clear liability approaches, taking into account the degree of autonomy of artificial intelligence, potential risks, and the need for further development of artificial intelligence technologies. The possibility of incorporating rules for the use of artificial intelligence into standards for the organizing medical care is considered. The importance of developing rules for allocating liability between doctor-robot and human-robot in disease diagnosis and treatment, depending on the degree of autonomy of the artificial intelligence system in decision-making is emphasized. The article concludes that ethical rules, patient informing, and digital training of medical professionals are necessary.